151 studies found for:    "idiopathic pulmonary fibrosis"
Show Display Options
Rank Status Study
1 Unknown  Azathioprine and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Placebo;   Drug: AZAPRED
2 Active, not recruiting Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: Standard pulmonary rehabilitation program
3 Not yet recruiting Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
4 Active, not recruiting Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: inhaled carbon monoxide;   Other: Oxygen
5 Recruiting The Effect of Pirfenidone on Cough in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: Cough monitor
6 Unknown  68Ga-DOTA-NOC PET/CT in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Procedure: 68Ga-DOTA-NOC PET/CT
7 Not yet recruiting Azithromycin in Idiopathic Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis;   Cough
Interventions: Drug: azithromycin;   Drug: placebo
8 Not yet recruiting The Role of Gastric Content Microaspirations in the Pathogenesis of Idiopathic Pulmonary Fibrosis
Condition: IDIOPATHIC PULMONARY FIBROSIS
Intervention:
9 Not yet recruiting A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Standard Steroid Treatment;   Drug: The Standard Steroid Treatment, Plasma Exchange and rituximab
10 Withdrawn Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Macitentan
11 Completed Safety and Tolerability Study of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: FG-3019
12 Completed A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: Placental MSC
13 Recruiting Study of Autologous Mesenchymal Stem Cells to Treat Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Biological: Endobronchial infusion of adult mesenchymal stem cells;   Biological: Autologous mesenchymal stem cells derived from bone marrow
14 Recruiting Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
15 Recruiting Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Cotrimoxazole;   Drug: Placebo
16 Completed
Has Results
Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: ACT-064992 (macitentan);   Drug: Placebo
17 Recruiting Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: FG-3019;   Drug: Placebo
18 Completed Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: bosentan;   Drug: Placebo
19 Completed Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With Thalidomide
Conditions: Idiopathic Pulmonary Fibrosis;   Cough
Interventions: Drug: Thalidomide;   Drug: Placebo
20 Completed Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years